The Future of Drug Device Combination Products in Chronic Disease Management
Chronic diseases such as diabetes, cardiovascular disorders, respiratory illnesses, and cancer continue to challenge healthcare systems globally. According to the World Health Organization (WHO), chronic diseases account for nearly 74% of all deaths worldwide, making effective management a top priority for medical innovators. One of the most promising advancements in this field is the rise of drug device combination products —a technology that merges pharmaceutical compounds with advanced delivery devices to improve patient outcomes. This integration is not only transforming treatment approaches but also shaping the future of chronic disease management with a focus on precision, convenience, and improved compliance. What Are Drug Device Combination Products? Drug device combination products (DDCPs) are therapeutic solutions that unite a pharmaceutical component (such as a drug or biologic) with a medical device. These products are designed to optimize drug delivery, enhance safety, ...